ServiceNow [NOW]
As of 2026-07-29. Spot $115.76. The memo issues no position verdict; this file scores the Liquidity Criteria and states which vehicle would be correct if the book chose to own it.
| Measure | Value |
|---|---|
| Market capitalisation (diluted) | $120.4bn |
| Enterprise value | $121.2bn |
| Trailing 252-day realised volatility | 54.6% |
| 252-day price range | $83.00 – $198.64 (spot 41.7% below the high) |
Sufficient for any size this book would take. Single-name cap is 20% of the book; NOW absorbs it without market impact.
Chosen vehicle: EQUITY (ladder step 1). No argument required, and none is offered.
Measured on the January 2027 chain (Alpaca options snapshot, 2026-07-29):
| Contract | Bid × size | Ask × size | Spread | Open interest | IV | Delta |
|---|---|---|---|---|---|---|
NOW270115C00100000 |
26.82 × 492 | 27.38 × 35 | 2.1% | 5,523 | 55.3% | 0.743 |
NOW270115C00120000 |
17.30 × 285 | 17.73 × 81 | 2.5% | 5,582 | 56.7% | 0.569 |
NOW270115C00130000 |
— | — | — | 5,523 | — | — |
NOW270115C00140000 |
10.73 × 251 | 11.31 × 278 | 5.3% | 5,808 | 57.2% | 0.413 |
IV 56.7% − realised 54.6% = +2.1 percentage points.
This is the narrowest implied-over-realised premium recorded in this project. The five large-software names in the enterprise cluster carried 11–15 points; CRDO carried 17 points at 108% implied. On the numbers alone, NOW is the first name where a LEAP does not require paying an unreasonable premium for convexity.
NOW270115C00120000: 285 × 81, a 2.5% spread, 5,582 open interest. NOW270115C00100000: 492 × 35.
This is genuine depth at the strike — comparable to CRM's 456 × 346 (the deepest in the cluster) and far better
than WDAY's 182 × 121, PANW's 18 × 8 at a single strike, or HCA's 18 contracts across an entire expiry. The
chain and the strike both pass.
There is none, and the reason is not liquidity.
The LEAP is available on better terms than any name yet checked in this project. It is still wrong, because the Valuation Criteria FAILs at −13.2pp and is robust across terminal margins from 15% to 31%. Paying even a 2.1-point volatility premium for leveraged convexity on a name whose five-year implied path requires a 35.7% revenue CAGR against 22.5% demonstrated is buying leverage on an unachievable path. The correct conclusion from a cheap option on a failing thesis is not to buy the option.
Absent an argument, the vehicle is equity — and here there is no position to construct at all until the Valuation Criteria changes.
The January 2027 expiry is 5.6 months out. The declared thesis horizon is 12 months for the target and 5 years for the implied path. No expiry is both liquid and long enough, which by the criteria's own rule means the answer is equity. Stated rather than resolved silently.
The Valuation Criteria fails on the exit multiple, not the terminal margin. Two mechanically distinct routes:
Monitoring trigger: cRPO constant-currency growth. It has printed 20% → 21% → 21.5% and is guided to 20% for Q3 2026. A print above 22% would be the first acceleration in three years and would materially change the demonstrated rate; a print below 18% would break the stabilisation read that underpins the 12-month target.